Clinical utility of indentifying metabolic syndrome (MetS) in patients with type 2 diabetes for primary cardiovascular disease (CVD) prevention: a population-based study

Sep-07

AUTHORS : Dr Iskandar Idris, University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital , Uttoxeter Road, Derby DE22 3DT – Email: Iskandar.Idris@nottingham.ac.uk – Profile: https://www.nottingham.ac.uk/medicine/people/iskandar.idris

JOURNAL : Diabetologia

REFERENCE: 50(S1):S433

DOI : 10.1007/s00125-007-0809-7

Clinical utility of indentifying metabolic syndrome (MetS) in patients with type 2 diabetes for primary cardiovascular disease (CVD) prevention: a population-based study

More publications

Association Between Type 2 Diabetes Onset Age and Risk of Cardiovascular Disease and Mortality: Two Cohort Studies from United Kingdom and Hong Kong

Characteristics of Patients With Atherosclerotic Cardiovascular Disease in Belgium and Current Treatment Patterns for the Management of Elevated LDL-C Levels

Unveiling unique clinical phenotypes of hip fracture patients and the temporal association with cardiovascular events